 |
anti-HER2 bispecific antibody drug conjugate |
|---|---|
| Trade Name | |
| Orphan Indication | Ovarian cancer |
| USA Market Approval | USA |
| USA Designation Date | 2016-07-06 00:00:00 |
| Sponsor | Zymeworks Inc.;18 West Mercer Street, Suite 370;Seattle, Washington, 98119 |
| |
anti-HER2 bispecific antibody drug conjugate |
|---|---|
| Trade Name | |
| Orphan Indication | Ovarian cancer |
| USA Market Approval | USA |
| USA Designation Date | 2016-07-06 00:00:00 |
| Sponsor | Zymeworks Inc.;18 West Mercer Street, Suite 370;Seattle, Washington, 98119 |